Edit |   |
---|---|
Antigenic Specificity | PD-L1 (Atezolizumab biosimilar) |
Clone | monoclonal |
Host Species | Humanized |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | Protein A/G purified, low endotoxin |
Size | 100mg |
Concentration | 1.0 - 5.0 mg/ml |
Applications | RUO |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Specificity: detects human PDL-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Atezolizumab. Atezolizumab biosimilar is an Fc-engineered, humanized, monoclonal antibody that binds to PD-L1 and blocks interactions with the PD-1 and B7.1 receptors. Atezolizumab biosimilar is a non-glycosylated IgG1 kappa immunoglobulin that has a calculated molecular mass of 145 kDa. |
Immunogen | n/a |
Other Names | Programmed cell death 1 ligand 1, Cd274, PDCD1 ligand 1, Programmed death ligand 1, B7 homolog 1, B7-H1, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1, PDL-1 |
Gene, Accession # | UniProt: Q9NZQ7 |
Catalog # | ICH4018-100mg |
Price | $5000 |
Order / More Info | PD-L1 (Atezolizumab biosimilar) Antibody from ICHORBIO |
Product Specific References | n/a |
U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio